a2m
  • a2m
  • Services
    • Strategy
    • Market Access and Reimbursement
    • Health Economic Modelling
    • Pricing and Valuation
    • Biotechnology
    • Nutrition
  • Capabilities
  • Latest News
  • About
  • Publications
  • Achievements
  • Contact
  • Home
  • Bedankt

Bedankt voor uw bericht

Latest News Blog
  • 3
    Dec
    Innovation Premium for Innovative Orphan Drugs in Oncology and Rare Diseases
  • 25
    Nov
    Guest lecture for Colombian American Chamber of Commerce on Pricing Policy for Orphan Drugs
  • 12
    Sept
    Milestone of more than 10’000 views on our policy paper challenging the ICER
Copyright by a2m, Mark Nuijten, 2018. All rights reserved.